01/26/23 9:00 AMNasdaq : GOVX, GOVXW conferencesGeoVax to Present at the 2023 BIO CEO & Investor Conferencevia NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today that its Chairman and CEO, David Dodd, will present at the 2023 BIO CEO &RHEA-AIneutral
01/25/23 11:00 AMNasdaq : GOVX, GOVXW GeoVax Receives Notice of Allowance for Zika Vaccine PatentGeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases,RHEA-AIneutral
01/04/23 9:00 AMNasdaq : GOVX, GOVXW conferencesGeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2023via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced today that it will present at the Biotech Showcase coinciding with the 41st AnnualRHEA-AIneutral
12/20/22 9:00 AMNasdaq : GOVX, GOVXW Valerie Montgomery Rice, MD, FACOG, President and CEO of Morehouse School of Medicine, Appointed Special Advisor to GeoVaxGeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccinesRHEA-AIneutral
12/07/22 4:00 PMNasdaq : GOVX, GOVXW managementGeoVax Appoints Jayne Morgan, M.D., to its Board of DirectorsGeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announcedRHEA-AIneutral
11/28/22 10:15 AMNasdaq : GOVX, GOVXW conferencesGeoVax to Present at the World Vaccine & Immunotherapy Congress West Coast 2022GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing vaccines and immunotherapies against infectiousRHEA-AIneutral
11/09/22 4:00 PMNasdaq : GOVX, GOVXW earningsGeoVax Reports 2022 Third Quarter Financial Results and Provides Corporate Updatevia NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapiesRHEA-AIneutral
10/26/22 9:00 AMNasdaq : GOVX, GOVXW conferencesearningsGeoVax to Host Third Quarter 2022 Business Update and Financial Results Conference Call on November 9, 2022via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines for cancer and infectious diseases, announced today that it will report third quarter 2022 financial results after theRHEA-AIneutral
10/11/22 9:00 AMNasdaq : GOVX, GOVXW conferencesGeoVax to Present at Vaccines Summit-2022via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancerRHEA-AIneutral
10/06/22 9:00 AMNasdaq : GOVX, GOVXW conferencesGeoVax to Present at Upcoming Investor Conferencesvia NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today announced that its Chairman & CEO, David Dodd, will present at the Midcap Rodeo: Windy CityRHEA-AIneutral
